There was however a non-significant trend towards patients with tumours expressing low levels of caspase-9 protein having a worse RFS, which may reflect the importance of caspase-9 as an effector molecule of apoptotic cell death following treatment with current therapeutics. Here, CASP9 is linked to neoplasm.